Haleon plc (HLN)
USD 9.71
(-2.02%)
USD 9.71
(-2.02%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.04 Billion GBP | -1.04% |
| 2022 | 1.06 Billion GBP | -23.74% |
| 2021 | 1.39 Billion GBP | 21.4% |
| 2020 | 1.14 Billion GBP | 74.81% |
| 2019 | 655 Million GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 423 Million GBP | 14200.0% |
| 2024 Q2 | 303 Million GBP | -28.37% |
| 2023 Q4 | -3 Million GBP | -100.82% |
| 2023 FY | 1.04 Billion GBP | -1.04% |
| 2023 Q3 | 365 Million GBP | 22.48% |
| 2023 Q2 | 298 Million GBP | -23.39% |
| 2023 Q1 | 389 Million GBP | 96.46% |
| 2022 Q3 | 345 Million GBP | 71.64% |
| 2022 Q1 | 343 Million GBP | -35.04% |
| 2022 Q4 | 198 Million GBP | -42.61% |
| 2022 FY | 1.06 Billion GBP | -23.74% |
| 2022 Q2 | 201 Million GBP | -41.4% |
| 2021 Q2 | 258 Million GBP | 10.73% |
| 2021 Q3 | 371 Million GBP | 43.8% |
| 2021 Q4 | 528 Million GBP | 42.32% |
| 2021 Q1 | 233 Million GBP | 0.0% |
| 2021 FY | 1.39 Billion GBP | 21.4% |
| 2020 FY | 1.14 Billion GBP | 74.81% |
| 2019 FY | 655 Million GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | -83.99 Million USD | 1348.914% |
| Bausch Health Companies Inc. | -592 Million USD | 277.196% |
| Catalent, Inc. | -1.04 Billion USD | 200.575% |
| Emergent BioSolutions Inc. | -760.5 Million USD | 237.936% |
| Elanco Animal Health Incorporated | -1.23 Billion USD | 185.215% |
| Perrigo Company plc | -12.7 Million USD | 8359.843% |
| Teva Pharmaceutical Industries Limited | -559 Million USD | 287.657% |
| Zoetis Inc. | 2.34 Billion USD | 55.247% |